Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Molecular Therapy. Methods & Clinical Development
|
December 13, 2021
Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL
Biping Deng, Jing Pan, Zhaoli Liu, et al.
Blood
|
July 25, 2025
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
Jing Pan, Liping Zhao, Yibing Zhang, et al.
Blood Advances
|
September 14, 2021
Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma
Ying Liu, Biping Deng, Bo Hu, et al.
Journal of Affective Disorders
|
June 2, 2024
Graph convolutional network with attention mechanism improve major depressive depression diagnosis based on plasma biomarkers and neuroimaging data
Chaonan Jiang, Bo Lin, Xinyi Ye, et al.
Nature Medicine
|
October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2021
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
Jing Pan, Yue Tan, Guoling Wang, et al.
The Lancet. Oncology
|
October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
Jing Pan, Kaiting Tang, Yuechen Luo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 8, 2024
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial
Liping Zhao, Chuo Li, Shiyu Zuo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2025
Differentiation Stage Predicts Radiosensitivity in Mesenchymal-Like Pancreatic Cancer
Tingshi Su, Xinjian Yu, Mojtaba Hoseini-Ghahfarokhi, et al.
Nature Communications
|
July 22, 2024
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial
Shiyu Zuo, Chuo Li, Xiaolei Sun, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Molecular Therapy. Methods & Clinical Development
|
December 13, 2021
Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL
Biping Deng, Jing Pan, Zhaoli Liu, et al.
Blood
|
July 25, 2025
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
Jing Pan, Liping Zhao, Yibing Zhang, et al.
Blood Advances
|
September 14, 2021
Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma
Ying Liu, Biping Deng, Bo Hu, et al.
Journal of Affective Disorders
|
June 2, 2024
Graph convolutional network with attention mechanism improve major depressive depression diagnosis based on plasma biomarkers and neuroimaging data
Chaonan Jiang, Bo Lin, Xinyi Ye, et al.
Nature Medicine
|
October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 29, 2021
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
Jing Pan, Yue Tan, Guoling Wang, et al.
The Lancet. Oncology
|
October 20, 2023
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
Jing Pan, Kaiting Tang, Yuechen Luo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
September 8, 2024
Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial
Liping Zhao, Chuo Li, Shiyu Zuo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 3, 2025
Differentiation Stage Predicts Radiosensitivity in Mesenchymal-Like Pancreatic Cancer
Tingshi Su, Xinjian Yu, Mojtaba Hoseini-Ghahfarokhi, et al.
Nature Communications
|
July 22, 2024
C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial
Shiyu Zuo, Chuo Li, Xiaolei Sun, et al.
Page
of 6